TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $916,000 | +28.8% | 94,478 | +42.6% | 0.65% | +23.1% |
| Q1 2021 | $711,000 | -29.2% | 66,243 | -2.9% | 0.53% | -17.6% |
| Q4 2020 | $1,004,000 | +34.9% | 68,235 | +30.4% | 0.64% | +18.3% |
| Q3 2020 | $744,000 | +65.7% | 52,341 | -5.8% | 0.54% | +45.7% |
| Q2 2020 | $449,000 | – | 55,556 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|